1 | ARF1, BAX, BCL2L11, Calpain, CAPN1, CCNG2, CD274, CDKN1C, CRABP1, EEF1D, FOS, GALNT11, GRASP, ID2, ING1, JUN, JUNB, MGEA5, MYCN, NFYA, OSBP2, PDCD1, PDCD4, SPRY4, VIM, ZFP36 | Caspase, Cyclin A, Cytochrome C, FGF, Hexokinase, Proteasome, Rb, Smad, Ubiquitin | 46 | Cell cycle, cell death, neurological disease |
2 | ADM, CXCL1, DUSP1, DUSP4, DUSP6, IER2, GADD45, GADD45A, GADD45B, GADD45G, IGF2, JUN/JUNB/JUND, KLF2, MKP1/2/3/4, MXD1, THBD, Thyroid hormone receptor, PDGF-AB, PDGF-AA, PDGFA, PHLDA1, PNRC1, RASD1, VAV3 | ERK, GC-GCR dimer, JINK1I2, Laminin, N-cor, Notch, Pak, Rar, Rxr, SWI-SNF, VitaminD3-VDR-RXR | 29 | Cancer, cellular growth, and proliferation, respiratory disease |
3 | ATAD4, BMF, Cbp/p300, CBX4, CREBBP, DLX2, EPHA4, GABARAPL1, MED26, MLL, MSX1, MYLK2, NOC2L, OSGIN1, PDXK, PLA2, PLA2G6, SENP3, WISP2 | Actin, Calmodulin, Ck2, ERK1l2, FSH, Histone h3, Histone h4, Hsp70, MAPK, Pka, Pld, PP2A, RGS2, RNA polymerase II, STAT5a/b, Tubulin | 29 | Skeletal and muscular system development and function, cancer, cell-to-cell signaling and interaction |
4 | CARD9, CCL5, CDKN2C, CXCL2, Cyclooxygenase, DUSP2, IER3, IFN-b, IL6, IRF9, MUC2, ND2, PIM2 (includes EG:11040), RGS16, RSAD2, SELPLG, SOCS1, TLR, TLR1, TNFAIP3 | ALP, Hsp27, IFN-a, IFN-g, IgG, IL1, IL12, IRF, JAK, LDL, MHC Class I, NF-κB, STAT, TGF-β | 27 | Connective tissue disorders, genetic disorder, immunological disease |
5 | CTGF, CXCR4, DLL1, DUSP8, EDN1, EREG, ERN1 (includes EG:2081), MBTPS1, MYH3, Myosin, OASL, PTGS2, SNAI1, SP100, SYNJ1, THRA, VEGF | ADCY, Calcineurin protein(s), G-protein-β, HBEGF, HCG, Ige, IKK, JNK, Mek, MMP, Nos, p38 MAPK, p70 S6k, Pkc(s), PLC, PLC-g, Tyrosine kinase | 26 | Cell cycle, cancer, skeletal and muscular system development and function |